Dear Sir I read the summary of your article and I find it very interesting, but I have some questions I'd like to share with you.

What is the mechanism of action of a peptide to inhibit the JNK signaling pathway?

How does a peptide, injected at subconjunctival level, can produce a decrease in intraocular inflammation?

Sincerely

J.M. Lou-Bonafonte

Article Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide...

Similar questions and discussions